NEW YORK CITY -- Douglas A. Michels, president and CEO of OraSure Technologies, Inc., and Dr. Jack C. Chow, assistant director general for HIV/AIDS, TB and Malaria at the World Health Organization (WHO), presided over the market open ceremony today. 

OraSure Technologies is the manufacturer of OraQuickÂ® ADVANCE, the only U.S. FDA-approved rapid, HIV-1/2 test that can be used with oral fluid, whole blood and plasma and produce results in 20 minutes. 

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. 

OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV-1. 

News

HAIs

 health care-acquired infections (HAIs) page presents updates on the latest techniques and strategies in the never-ending battle between infection preventionists and HAIs. Focusing on the latest in medical literature, we also present perspectives from the top infection preventionists and other medical experts in the country about how to put the growing knowledge of HAIs into use in the everyday world of infection prevention. Articles and videos often focus on methods to contain and control pathogens and multidrug-resistant organisms from spreading within the health care system.

OraSure Technologies, Inc. and the World Health Organization Open the NASDAQ Stock Market in Recognition of World AIDS Day